Can I Take Valproic Acid and Lamotrigine Together?

Yes, valproic acid and lamotrigine are often prescribed together for seizure control and mood disorders, but the combination involves a documented moderate interaction. The presence of valproic acid changes how lamotrigine is processed and distributed in your body, which may require a dosage adjustment. This interaction is well-documented in drug labeling and monitoring is standard practice when both medications are used together.

What the Source Says

According to FDA drug labeling data, valproic acid and lamotrigine interact at a moderate severity level. The documented source record states:

Valproate can affect pharmacokinetics by inhibiting metabolism or protein binding displacement. Dosage adjustment may be necessary.

This information is drawn from the FDA labeling for valproic acid and represents established clinical knowledge about how these two anticonvulsant medications interact when used in the same patient. The record indicates that the interaction is significant enough to warrant close attention but is manageable with appropriate monitoring and dosing strategies.

How to Understand This

To make sense of this interaction, it helps to know what happens to lamotrigine in your body normally and how valproic acid changes that process.

Normal Lamotrigine Processing

When you take lamotrigine by itself, your liver breaks down (metabolizes) the drug through a biochemical pathway. The drug is also carried through your bloodstream by attaching to proteins. These two processes—metabolism and protein binding—control how much active lamotrigine remains available in your body at any given time, and how quickly it is eliminated.

What Valproic Acid Does

The documented mechanism of this interaction involves two possible effects: inhibition of metabolism or protein binding displacement.

Inhibition of metabolism means valproic acid slows down the liver's ability to break down lamotrigine. When metabolism slows, lamotrigine accumulates in your body at higher concentrations than expected. This is sometimes called an increase in lamotrigine exposure.

Protein binding displacement refers to a different mechanism: valproic acid and lamotrigine may compete for space on the proteins that carry them through the bloodstream. If valproic acid displaces lamotrigine from these protein carriers, more lamotrigine becomes unbound and active in the bloodstream. This also increases the amount of active drug available.

The source record does not specify which of these mechanisms (or both) occurs in a given patient, only that one or both are possible. In clinical practice, the net result is the same: when valproic acid is present, lamotrigine levels tend to be higher than they would be without valproic acid.

Why This Matters

Lamotrigine is dose-sensitive. Higher-than-expected levels can increase the risk of adverse effects, including dizziness, blurred vision, lack of coordination, and—rarely—serious skin reactions. This is why dosage adjustment is often necessary when valproic acid is added to (or removed from) a regimen that includes lamotrigine.

Who Should Pay Particular Attention

This interaction is relevant for anyone taking both medications together. However, careful monitoring is especially important for:

• Patients whose lamotrigine dosage was stable before valproic acid was started. When valproic acid is introduced, lamotrigine levels may rise unexpectedly.
• Patients whose valproic acid dosage is changing, since adjustments to valproic acid can shift how much lamotrigine accumulates in the body.
• Patients who have recently stopped valproic acid. When valproic acid is withdrawn, lamotrigine metabolism may speed up again, potentially lowering lamotrigine levels.
• Patients with kidney or liver disease, which can independently affect how both drugs are processed.
• Patients taking other medications that interact with lamotrigine or valproic acid, creating a more complex drug-interaction picture.

Hypothetical Example 1: Adding Valproic Acid to Existing Lamotrigine

Suppose a patient has been taking lamotrigine 150 mg twice daily for seizure control and is doing well. A physician then prescribes valproic acid 500 mg twice daily for mood stabilization. Because valproic acid inhibits lamotrigine metabolism (or displaces it from protein binding), the lamotrigine concentration in the patient's blood begins to rise, even though the patient is taking the same 150 mg dose. Within days or weeks, the patient might experience lamotrigine side effects—such as dizziness or blurred vision—even though nothing about their lamotrigine dose changed. This is a signal that the interaction has taken effect. The physician would typically lower the lamotrigine dose (perhaps to 100 mg twice daily) to keep the total lamotrigine exposure at a safe and effective level. This dosage adjustment accounts for the inhibitory effect of valproic acid.

Hypothetical Example 2: Stopping Valproic Acid While Continuing Lamotrigine

Now suppose the same patient later decides—with physician guidance—to discontinue valproic acid. As valproic acid leaves the body, it no longer inhibits lamotrigine metabolism or displaces it from protein binding. Lamotrigine metabolism speeds back up. The patient's lamotrigine level drops, even though they are still taking the reduced dose (100 mg twice daily) that was appropriate when valproic acid was present. Over time, seizure control may weaken or mood symptoms may return. The physician would need to increase the lamotrigine dose again (perhaps back toward 150 mg twice daily or higher) to restore adequate drug levels. This example illustrates why dosage changes should always be made under medical supervision and why close monitoring is needed whenever one drug in an interacting pair is started, stopped, or adjusted.

What to Discuss With a Pharmacist or Physician

If you are taking (or are about to start) both valproic acid and lamotrigine, here are key questions and considerations to raise with your healthcare provider:

• Has my lamotrigine dose been adjusted for valproic acid? Since this is a documented interaction that often requires dosage adjustment, confirm that your current lamotrigine dose accounts for the presence of valproic acid.
• What dosage should I expect, and why? Ask your pharmacist to explain the reasoning behind your specific lamotrigine dose in the context of valproic acid use.
• What signs or symptoms should alert me to a dosage problem? Lamotrigine side effects such as dizziness, blurred vision, poor coordination, tremor, or rash can signal that levels are too high. Conversely, return of seizures or mood symptoms might mean levels are too low. Knowing what to watch for helps you communicate early warning signs to your care team.
• How often will my medications be monitored? Ask about the plan for blood tests (if any), clinical follow-up visits, and how quickly you should contact your provider if you notice changes.
• What happens if my valproic acid dose changes or if I stop it? Make sure you understand that adding, stopping, or adjusting valproic acid will affect how much lamotrigine is active in your body, and that your lamotrigine dose may need to be adjusted in response.
• Are there other medications I should know about? Since both valproic acid and lamotrigine can interact with other drugs, make sure your provider is aware of all medications, supplements, and over-the-counter products you are taking.
• Should I avoid any specific foods or activities? While the interaction itself is a drug-drug interaction, your provider may have guidance about alcohol, diet, or lifestyle factors that affect either medication.

Do not change your dose, stop either medication, or add another medication without explicit guidance from your prescribing physician or pharmacist. The goal is to work together with your healthcare team to maintain effective drug levels while minimizing side effects.

Key Takeaways

• Valproic acid and lamotrigine have a documented moderate interaction. Both medications can be used together, but the combination requires careful management.
• Valproic acid changes lamotrigine levels by inhibiting metabolism or displacing protein binding, causing lamotrigine to accumulate in the body. This is why dosage adjustment is often necessary.
• Higher-than-expected lamotrigine levels increase the risk of side effects such as dizziness, blurred vision, and lack of coordination. Lower-than-expected levels may reduce seizure control or mood stability.
• Whenever valproic acid is started, stopped, or adjusted, your lamotrigine dose may need to change too. These adjustments should always be made under medical supervision.
• Close communication with your pharmacist and physician—and prompt reporting of new symptoms—helps ensure that both medications remain safe and effective for you.

Sources

• U.S. FDA Drug Labeling — Official FDA-approved prescribing information for valproic acid and lamotrigine.
• DailyMed (NLM/NIH) — Comprehensive, regularly updated drug labeling, including FDA-approved product information and documented interactions.
• RxNorm (NLM/NIH) — Standardized naming and classification of drugs and drug interactions in the U.S. healthcare system.
• PubMed (NLM/NIH) — Gateway to peer-reviewed biomedical literature; search terms such as "valproic acid lamotrigine interaction" retrieve relevant clinical studies and reviews.

Next Steps

If you are taking valproic acid and lamotrigine, or are considering starting one or both medications, visit checkdruginteractions.com to check your full medication list for potential interactions. Use the tool to review all your current medications, supplements, and over-the-counter products. Then confirm your medication plan, dosages, and any necessary adjustments with your pharmacist or physician. They can explain how this particular interaction applies to your unique health situation and ensure you are receiving the safest and most effective treatment.